Proteomic, immunopeptidomic, and immunofluorescence analyses validate neoproteins as tumor-restricted antigens, revealing a therapeutically actionable cancer dark proteome controlled by one oncogenic fusion.
Luuk A. Broeils, Jill Pilet, Mariia K. Koshkina et al.· bioRxiv· 0 citations
Neuroblastoma (NB) is an embryonal malignancy of the sympathetic nervous system that arises in either the adrenal gland or sympathetic ganglia. However, its developmental origin and the earliest steps of tumor initiation remain incompletely understood. We investigated how ALK activating mutations and MYCN overexp...
Nour El Houda Djerir, Amira Kramdi, Cécile Thirant et al.· Cancer Research· 0 citations
PURPOSE
Rhabdoid tumors (RTs) are highly aggressive pediatric cancers driven by the biallelic inactivation of the SMARCB1 tumor suppressor gene, the sole recurrent genetic alteration. SMARCB1 encodes a core subunit of the SWI/SNF chromatin remodeling complex; its loss disrupts epigenetic gene regulation, supporting the...
C. Chauvin, Ryszard Wimmer, Ludovica Brunetti et al.· Clinical Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.